
In a phase I trial, 28 patients with advanced solid tumors were given zzso daily for 5 days by zzso infusion over 20 minutes at zzso zzso The total dose for each course ranged from 25 to 150 zzso in six escalation zzso zzso was zzso with a zzso count depression regularly observed at doses of greater than or equal to zzso zzso zzso occurred only at higher zzso zzso was zzso and vomiting did not zzso There were no adverse drug-related effects on zzso or zzso zzso No zzso activity was zzso A dose range of zzso zzso zzso for each zzso course zzso zzso is recommended for phase II zzso 

